Pharmacological stimulation of locus coeruleus reveals a new antipsychotic-responsive pathway for deficient sensorimotor gating

Neuropsychopharmacology

Volumn 36, Issue 8, 2011, Pages 1656-1667

  Alsene, Karen M ^a   Bakshi, Vaishali P ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

catecholamines; locus ceruleus; norepinephrine; Quetiapine; startle; Zyprexa

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; BETHANECHOL; CLONIDINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PRAZOSIN; QUETIAPINE; RITANSERIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENDOPHENOTYPE; FOREBRAIN; GILLES DE LA TOURETTE SYNDROME; LOCUS CERULEUS; MALE; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC SYSTEM; PHARMACOLOGICAL STIMULATION; POSTTRAUMATIC STRESS DISORDER; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SENSORIMOTOR CORTEX; STARTLE REFLEX;

EID: 85027949579     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.47     Document Type: Article

References (62)

1. Alsene KM, Carasso BS, Connors EE, Bakshi VP (2006). Disruption of prepulse inhibition after stimulation of central but not peripheral alpha-1 adrenergic receptors. Neuropsychopharma-cology 31: 2150-2161. (Pubitemid 44413192)
2. Alsene KM, Fallace K, Bakshi VP (2010). Ventral striatal noradrenergic mechanisms contribute to sensorimotor gating deficits induced by amphetamine. Neuropsychopharmacology 35: 2346-2356.
3. Alsene KM, Rajbhandari AK, Ramaker MJ, Bakshi VP (2011). Discrete forebrain neuronal networks supporting noradrenergic regulation of sensorimotor gating. Neuropsychopharmacology 36: 1003-1014.
4. Aston-Jones G, Bloom FE (1981). Norepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli. J Neurosci 1: 887-900. (Pubitemid 11025877)
5. Aston-Jones G, Cohen JD (2005). Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance. J Comp Neurol 493: 99-110. (Pubitemid 41637975)
6. Bakshi VP, Geyer MA (1995). Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacology (Berl) 122: 198-201. (Pubitemid 26019155)
7. Bakshi VP, Geyer MA (1997). Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist. J Pharmacol Exp Ther 283: 666-674. (Pubitemid 27514625)
8. Berridge CW, Abercrombie ED (1999). Relationship between locus coeruleus discharge rates and rates of norepinephrine release within neocortex as assessed by in vivo microdialysis. Neuroscience 93: 1263-1270. (Pubitemid 29397554)
9. Berridge CW, Foote SL (1991). Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus. J Neurosci 11: 3135-3145.
10. Berridge CW, Page ME, Valentino RJ, Foote SL (1993). Effects of locus coeruleus inactivation on electroencephalographic activity in neocortex and hippocampus. Neuroscience 55: 381-393. (Pubitemid 23211350)
11. Berridge CW, Waterhouse BD (2003). The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 42: 33-84. (Pubitemid 36369264)
12. Boehnlein JK, Kinzie JD (2007). Pharmacologic reduction of CNS noradrenergic activity in PTSD: the case for clonidine and prazosin. J Psychiatr Pract 13: 72-78. (Pubitemid 46588308)
13. Braff DL, Greenwood TA, Swerdlow NR, Light GA, Schork NJ (2008). Advances in endophenotyping schizophrenia. World Psychiatry 7: 11-18. (Pubitemid 351338180)
14. Bymaster F, Perry KW, Nelson DL, Wong DT, Rasmussen K, Moore NA. et al (1999). Olanzapine: a basic science update. Br J Psychiatry (Suppl 37); 36-40. (Pubitemid 29089310)
15. Bymaster FP, Hemrick-Luecke SK, Perry KW, Fuller RW (1996). Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, alpha 1-adrenergic and muscarinic receptors in vivo in rats. Psychopharmacology (Berl) 124: 87-94. (Pubitemid 26111437)
16. Carasso BS, Bakshi VP, Geyer MA (1998). Disruption in prepulse inhibition after alpha-1 adrenoceptor stimulation in rats. Neuropharmacology 37: 401-404. (Pubitemid 28282646)
17. Dawe GS, Huff KD, Vandergriff JL, Sharp T, O'Neill MJ, Rasmussen K (2001). Olanzapine activates the rat locus coeruleus: in vivo electrophysiology and c-Fos immunoreactivity. Biol Psychiatry 50: 510-520. (Pubitemid 32971882)
18. Devilbiss DM, Waterhouse BD (2004). The effects of tonic locus ceruleus output on sensory-evoked responses of ventral posterior medial thalamic and barrel field cortical neurons in the awake rat. J Neurosci 24: 10773-10785. (Pubitemid 39602389)
19. Devilbiss DM, Waterhouse BD (2011). Phasic and tonic patterns of locus coeruleus output differentially modulate sensory network function in the awake rat. J Neurophysiol 105: 69-87.
20. Escanilla O, Arrellanos A, Karnow A, Ennis M, Linster C (2010). Noradrenergic modulation of behavioral odor detection and discrimination thresholds in the olfactory bulb. Eur J Neurosci 32: 458-468.
21. Fendt M, Li L, Yeomans JS (2001). Brain stem circuits mediating prepulse inhibition of the startle reflex. Psychopharmacology (Berl) 156: 216-224. (Pubitemid 32702214)
22. Foote SL, Aston-Jones G, Bloom FE (1980). Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal. Proc Natl Acad Sci USA 77: 3033-3037. (Pubitemid 10031725)
23. Gay N, Cottraux JA, Denoroy L, Tommasi M, Kopp N (1989). Possible increase of dopamine-beta-hydroxylase activity in the locus ceruleus of paranoid schizophrenic patients: a preliminary post-mortem study. Psychiatry Res 27: 31-38. (Pubitemid 19042423)
24. Geracioti Jr TD, Baker DG, Ekhator NN, West SA, Hill KK, Bruce AB et al (2001). CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatry 158: 1227-1230. (Pubitemid 32717695)
25. Geyer MA (2008). Developing translational animal models for symptoms of schizophrenia or bipolar mania. Neurotox Res 14: 71-78.
26. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001). Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156: 117-154. (Pubitemid 32702206)
27. Geyer MA, Swerdlow NR, Mansbach RS, Braff DL (1990). Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull 25: 485-498. (Pubitemid 20346586)
28. Gould TJ, Rukstalis M, Lewis MC (2005). Atomoxetine and nicotine enhance prepulse inhibition of acoustic startle in C57BL/6 mice. Neurosci Lett 377: 85-90. (Pubitemid 40312414)
29. Hirata A, Aguilar J, Castro-Alamancos MA (2006). Noradrenergic activation amplifies bottom-up and top-down signal-to-noise ratios in sensory thalamus. J Neurosci 26: 4426-4436. (Pubitemid 44315401)
30. Hurley LM, Devilbiss DM, Waterhouse BD (2004). A matter of focus: monoaminergic modulation of stimulus coding in mammalian sensory networks. Curr Opin Neurobiol 14: 488-495. (Pubitemid 39089088)
31. Jacobs BL, Abercrombie ED, Fornal CA, Levine ES, Morilak DA, Stafford IL (1991). Single-unit and physiological analyses of brain norepinephrine function in behaving animals. Prog Brain Res 88: 159-165.
32. Kamath A, Al-Khairi I, Bhardwaj S, Srivastava LK (2008). Enhanced alpha1 adrenergic sensitivity in sensorimotor gating deficits in neonatal ventral hippocampus-lesioned rats. Int J Neuropsychopharmacol 11: 1-12.
33. Lahdesmaki J, Sallinen J, MacDonald E, Scheinin M (2004). Alpha2A-adrenoceptors are important modulators of the effects of D-amphetamine on startle reactivity and brain monoamines. Neuropsychopharmacology 29: 1282-1293. (Pubitemid 38780651)
34. Lapiz MD, Morilak DA (2006). Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience 137: 1039-1049. (Pubitemid 43053965)
35. Leckman JF, Goodman WK, Anderson GM, Riddle MA, Chappell PB, McSwiggan-Hardin MT et al (1995). Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls. Neuropsychophar-macology 12: 73-86.
36. Lohr JB, Jeste DV (1988). Locus ceruleus morphometry in aging and schizophrenia. Acta Psychiatr Scand 77: 689-697.
37. Mansbach RS, Geyer MA, Braff DL (1988). Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychophar-macology (Berl) 94: 507-514. (Pubitemid 18087401)
38. Marner L, Soborg C, Pakkenberg B (2005). Increased volume of the pigmented neurons in the locus coeruleus of schizophrenic subjects: a stereological study. J Psychiatr Res 39: 337-345. (Pubitemid 40404082)
39. Minzenberg MJ, Watrous AJ, Yoon JH, Ursu S, Carter CS (2008). Modafinil shifts human locus coeruleus to low-tonic, high-phasic activity during functional MRI. Science 322: 1700-1702.
40. Mishima K, Tanoue A, Tsuda M, Hasebe N, Fukue Y, Egashira N et al (2004). Characteristics of behavioral abnormalities in alpha1-d-adrenoceptors deficient mice. Behav Brain Res 152: 365-373. (Pubitemid 38757908)
41. Moxon KA, Devilbiss DM, Chapin JK, Waterhouse BD (2007). Influence of norepinephrine on somatosensory neuronal responses in the rat thalamus: a combined modeling and in vivo multi-channel, multi-neuron recording study. Brain Res 1147: 105-123. (Pubitemid 46584661)
42. Nakano K (2000). Neural circuits and topographic organization of the basal ganglia and related regions. Brain Dev 22(Suppl 1): S5-16.
43. Oranje B, Kahn RS, Kemner C, Verbaten MN (2004). Modulating sensorimotor gating in healthy volunteers: the effects of desipramine and haloperidol. Psychiatry Res 127: 195-205. (Pubitemid 39024497)
44. Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Coordinates. Academic Press: San Diego.
45. Phillips MA, Langley RW, Bradshaw CM, Szabadi E (2000). The effects of some antidepressant drugs on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man. J Psychopharmacol 14: 40-45. (Pubitemid 30156537)
46. Pouzet B, Andersen MP, Hogg S (2005). Effects of acute treatment with antidepressant drugs on sensorimotor gating deficits in rats. Psychopharmacology (Berl) 178: 9-16. (Pubitemid 40298686)
47. Pudovkina OL, Cremers TI, Westerink BH (2002). The interaction between the locus coeruleus and dorsal raphe nucleus studied with dual-probe microdialysis. Eur J Pharmacol 445: 37-42. (Pubitemid 34628430)
48. Pudovkina OL, Kawahara Y, de Vries J, Westerink BH (2001). The release of noradrenaline in the locus coeruleus and prefrontal cortex studied with dual-probe microdialysis. Brain Res 906: 38-45. (Pubitemid 32595537)
49. Quednow BB, Kuhn KU, Stelzenmuelle R, Hoenig K, Maier W, Wagner M (2004). Effects of serotonergic and noradrenergic antidepressants on auditory startle response in patients with major depression. Psychopharmacology (Berl) 175: 399-406. (Pubitemid 39362037)
50. Ramirez OA, Wang RY (1986). Locus coeruleus norepinephrine-containing neurons: effects produced by acute and subchronic treatment with antipsychotic drugs and amphetamine. Brain Res 362: 165-170. (Pubitemid 16185435)
51. Robbins TW, Arnsten AF (2009). The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci 32: 267-287.
52. Sallinen J, Haapalinna A, Viitamaa T, Kobilka BK, Scheinin M (1998). Adrenergic alpha2C-receptors modulate the acoustic startle reflex, prepulse inhibition, and aggression in mice. J Neurosci 18: 3035-3042. (Pubitemid 28163233)
53. Sara SJ (2009). The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci 10: 211-223.
54. Schotte A, Janssen PF, Gommeren W, Luyten WH, Van Gompel P, Lesage AS et al (1996). Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl) 124: 57-73. (Pubitemid 26112775)
55. Svensson TH (2003). Alpha-adrenoceptor modulation hypothesis of antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry 27: 1145-1158. (Pubitemid 37464959)
56. Swerdlow NR, Bakshi V, Geyer MA (1996). Seroquel restores sensorimotor gating in phencyclidine-treated rats. J Pharmacol Exp Ther 279: 1290-1299. (Pubitemid 27166777)
57. Swerdlow NR, Bongiovanni MJ, Tochen L, Shoemaker JM (2006). Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: implications for predictive validity and Tourette Syndrome. Psychopharmacology (Berl) 186: 246-254. (Pubitemid 43727342)
58. Swerdlow NR, Geyer MA, Braff DL (2001). Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl) 156: 194-215. (Pubitemid 32702213)
59. Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL (2008). Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl) 199: 331-388.
60. Valentino RJ, Foote SL, Page ME (1993). The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann NY Acad Sci 697: 173-188. (Pubitemid 24028963)
61. Van Gaalen M, Kawahara H, Kawahara Y, Westerink BH (1997). The locus coeruleus noradrenergic system in the rat brain studied by dual-probe microdialysis. Brain Res 763: 56-62. (Pubitemid 27323738)
62. Yamamoto K, Hornykiewicz O (2004). Proposal for a noradrena-line hypothesis of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 28: 913-922.